Visitor Guard® offers Medical Insurance for Indian Travelers, Amid Measles Surge in US

New Delhi [India], March 28:  Visitor Guard® offers comprehensive medical insurance, providing essential protection for Indian travelers heading to the United States, particularly in light of the current surge in measles cases. Given the heightened risk of infectious diseases, ensuring adequate travel insurance coverage is paramount.

The US, a popular destination for Indian tourists and business travelers, has witnessed a notable uptick in measles cases, particularly in regions with low vaccination rates. As a highly contagious viral disease, measles can lead to severe health complications, placing international travelers—especially those from countries with varying vaccination coverage—at increased risk.

“With measles spreading in certain areas, it is essential for travelers to have an insurance plan that covers new medical conditions while in the U.S., including emergency medical evacuation,” said Chiranth Nataraj, founder of Visitor Guard®. “Our newly introduced plans, such as Venbrook Basic and Venbrook Premier, have gained popularity by offering comprehensive medical and trip protection for international visitors.”

Travel Insurance for USA from India

The Venbrook Premier plan provides up to $1,000,000 in coverage for sickness and injuries with deductible options ranging from $0 to $5,000. It includes benefits for hospital stays, urgent care, in-office visits, emergency medical evacuation, prescription drugs, and more. Furthermore, the plan also offers Well Doctor Visit coverage, ensuring travelers have access to preventive care.

The Venbrook Basic plan offers similar essential protections with some coverage limitations, making it a cost-effective option for primary medical coverage. While neither plan covers vaccinations, both provide coverage for measles treatment like any other medical condition.

 “In addition to Venbrook Basic and Premier, we offer other popular plans such as Safe Travels USA Comprehensive, Patriot America, Atlas America, Visit USA, Visitor Care, and Safe Travels Elite,” Nataraj added. “These plans provide a safety net for visitors by offering medical and financial support for unforeseen illnesses and injuries during their stay.”

With high medical costs in the U.S., Indian travelers are strongly recommended to buy a travel medical insurance policy before their trip. Without adequate coverage, medical emergencies can lead to significant financial burdens. Travelers should carefully review their policy to ensure it includes sufficient coverage limits and assistance services to safeguard their health and finances.

About Visitor Guard®

Visitor Guard® is a leading provider of travel medical insurance plans for international travelers. Offering comprehensive coverage for a wide range of health issues, including medical emergencies, illness, and medical evacuation, Visitor Guard® ensures travelers are fully protected during their trips. With flexible plans and excellent customer service, Visitor Guard® provides peace of mind to travelers worldwide.

For more information on travel medical insurance plans, including coverage details and benefits, visit

Media Contact

If you have any objection to this press release content, kindly contact [email protected] to notify us. We will respond and rectify the situation in the next 24 hours.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More